Abstract
This Frost & Sullivan research service titled European Gastroenterology
Therapeutics Markets provides an overview of current treatment options,
technological advancements and revenues, along with a complete analysis of key
prevailing drivers, restraints and trends. In this research, Frost &
Sullivan' s expert analysts thoroughly examine the following market: proton
pump inhibitors, histamine-2 receptor antagonists, intestinal
anti-inflammatory agents, immunosuppressive agents.
This research service is available through our Pharmaceuticals & Biotechnology
Growth Partnership Services programme. With this programme, you receive
industry-leading market research such as this, along with technical and
econometric data and many interactive features including Analyst Inquiry Time
and Client Councils.
View Cart
